Integra LifeSciences Holdings (IART) — Cash Flow-to-Debt Ratio
Integra LifeSciences Holdings (IART) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $9.80 Million could theoretically repay 0% of its total liabilities ($2.54 Billion) in one year. Explore Integra LifeSciences Holdings (IART) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Integra LifeSciences Holdings Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Integra LifeSciences Holdings across 31 annual periods. Also explore Integra LifeSciences Holdings asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Integra LifeSciences Holdings (1995–2025)
Year-by-year debt coverage analysis for Integra LifeSciences Holdings. For market capitalisation and broader financial context, see market cap of Integra LifeSciences Holdings.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $50.38 Million | $2.56 Billion | ▼ -62.1% |
| 2024 | 0.05x | $129.38 Million | $2.49 Billion | ▼ -18.6% |
| 2023 | 0.06x | $139.96 Million | $2.19 Billion | ▼ -49.7% |
| 2022 | 0.13x | $264.47 Million | $2.09 Billion | ▼ -14.9% |
| 2021 | 0.15x | $312.43 Million | $2.10 Billion | ▲ +53.5% |
| 2020 | 0.10x | $203.83 Million | $2.10 Billion | ▼ -20.9% |
| 2019 | 0.12x | $231.43 Million | $1.89 Billion | ▲ +6.4% |
| 2018 | 0.12x | $199.68 Million | $1.73 Billion | ▲ +126.3% |
| 2017 | 0.05x | $114.54 Million | $2.25 Billion | ▼ -57.6% |
| 2016 | 0.12x | $116.41 Million | $968.29 Million | ▲ +30.2% |
| 2015 | 0.09x | $94.48 Million | $1.02 Billion | ▲ +1.6% |
| 2014 | 0.09x | $79.46 Million | $874.30 Million | ▼ -10.2% |
| 2013 | 0.10x | $53.27 Million | $526.05 Million | ▲ +11.4% |
| 2012 | 0.09x | $58.72 Million | $645.82 Million | ▼ -43.2% |
| 2011 | 0.16x | $104.33 Million | $651.47 Million | ▼ -21.5% |
| 2010 | 0.20x | $105.57 Million | $517.35 Million | ▼ -29.4% |
| 2009 | 0.29x | $143.24 Million | $495.22 Million | ▲ +172.6% |
| 2008 | 0.11x | $72.59 Million | $684.23 Million | ▲ +25.8% |
| 2007 | 0.08x | $47.03 Million | $557.58 Million | ▼ -62.7% |
| 2006 | 0.23x | $71.70 Million | $317.46 Million | ▼ -37.0% |
| 2005 | 0.36x | $56.85 Million | $158.61 Million | ▲ +36.9% |
| 2004 | 0.26x | $38.98 Million | $148.89 Million | ▲ +8.2% |
| 2003 | 0.24x | $34.83 Million | $144.00 Million | ▼ -79.5% |
| 2002 | 1.18x | $31.98 Million | $27.07 Million | ▲ +77.1% |
| 2001 | 0.67x | $15.70 Million | $23.53 Million | ▲ +540.3% |
| 2000 | -0.15x | $-4.96 Million | $32.73 Million | ▼ -271.5% |
| 1999 | 0.09x | $2.50 Million | $28.30 Million | ▲ +103.0% |
| 1998 | -2.97x | $-9.80 Million | $3.30 Million | ▲ +2.3% |
| 1997 | -3.04x | $-7.90 Million | $2.60 Million | ▲ +12.6% |
| 1996 | -3.48x | $-8.00 Million | $2.30 Million | ▼ -24.2% |
| 1995 | -2.80x | $-5.60 Million | $2.00 Million | — |